MorphoSys (MOR)
(Delayed Data from NSDQ)
$18.04 USD
-0.09 (-0.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.05 +0.01 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 30% (76 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.61 | 1.35 | 9.99 |
Current Quarter Estimate | -0.51 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.35 | 0.12 | 52.54 |
Next Quarter Estimate | -0.56 | 7.81 | 61.00 |
Next Year Estimate | -0.89 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -38.67 | 12.90 | 17.08 |
Next Year | 57.21 | 8.10 | 8.00 |
Last 5 Years | -247.70 | 1.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 51.18 | 2.01 |
Price/Cash Flow (MRFY) | NA | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -80.07% | -100.99% |
Return on Equity (TTM) | -694.31% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.